Showing 151–175 of 200 documents
Sorted by hybrid relevance (keyword + semantic via RRF)
Grasa Lozano CD, Baro-Fernández M, Rubio-San-Simón A, Blázquez-Gamero D, López-Roa P, et al.
Background There are no guidelines to screen haemato-oncologic children when a tuberculosis (TB) outbreak is suspected. Methods After exposition to an adult with active TB, children exposed from a haemato-oncology unit were screened according to immunosuppression status and time …
Arafa Djalal, Justin Côté-Daigneault
Inflammatory bowel disease (IBD) patients undergoing treatment with biological therapy are at increased risk of developing opportunistic infections such as tuberculosis (TB). Screening for latent tuberculosis is mandatory before initiating biological therapy such as Anti-TNF alph…
Maria Mironova, Irina Y. Gutierrez Puentes, Rajashree Anandakrishnan, Anil R. Balani
…or necrosis factor alpha (anti-TNF) medication used for the treatment of moderate-to-severe Crohn’s disease and ulcerative colitis. Tuberculosis (TB) has remained a serious side effect of anti-TNF therapy despite routine TB screening. We report a case of a young male who develope…
Pop R, Kaelin MB, Kuster SP, Sax H, Rampini SK, et al.
…d exposure to sputum smear positive tuberculosis (TB). NICE guidelines give support regarding investigation and treatment intervention, but not for contact definitions. Data regarding the reliability of any interferon gamma release assay (IGRA) in infants as a screening test for …
Farah Daas, Rafael Ruiz‐Gaviria, Bhakti Thummar, Naveera Khan, Sheena Ramdeen
…y (IGRA) is frequently ordered in hospitalized patients for latent tuberculosis (TB) screening. Health care workers must be cautioned that acute and critical illness exert a significant effect on IGRA performance, so delaying screening to the outpatient setting is preferred if fe…
Djalal A, Côté-Daigneault J
…ground Inflammatory bowel disease (IBD) patients undergoing treatment with biological therapy are at increased risk of developing opportunistic infections such as tuberculosis (TB). Screening for latent tuberculosis is mandatory before initiating biological therapy such as Anti-T…
Karat AS, Gregg M, Barton HE, Calderon M, Ellis J, et al.
…n to inform the 2019 update of global tuberculosis (TB) IPC guidelines, asked: do triage and/or isolation and/or effective treatment of TB disease reduce MTB transmission in healthcare settings? Of 25 included articles, 19 reported latent TB infection (LTBI) incidence in healthca…
Rebecca Berhanu, Karen R. Jacobson
…st benefit is observed in those with a positive result on a latent TB infection test, which is not ...References1. Samandari T, Agizew TB, Nyirenda S, et al. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a random…
Kendra Brett, Melissa Severn
It is not known if screening for latent tuberculosis infection (LTBI) is useful for reducing the risk of tuberculosis reactivation among people at risk (no evidence was found). In people with LTBI, providing treatment for the latent infection may be helpful for preventing the dev…
Adrienne E. Shapiro, Ayushi Gupta, Kristine F Lan, H. Nina Kim
…in the US is reactivation TB in non-US-born (nUSb) persons. Guidelines recommend screening persons born in high TB burden countries for latent TB infection (LTBI) and treating if positive. We evaluated the LTBI cascade in primary care among nUSb persons in a large academic medica…
…in the US is reactivation TB in non-US-born (nUSb) persons. Guidelines recommend screening persons born in high TB burden countries for latent TB infection (LTBI) and treating if positive. We evaluated the LTBI cascade in primary care among nUSb persons in a large academic medica…
World Health Organization
…perience since the publication of the 2021 consolidated HIV guidelines and aims to support progress towards ending AIDS as a public health threat by 2030. The document addresses the use of preferred and alternative antiretroviral regimens across different populations, including a…
Faiza Aiman Khan
…nd the world emphasize on its early detection and immediate treatment to reduce the transmission of infectious cases Primary Health care providers play an essential role in detecting and diagnosing suspected TB cases, and referring them for treatment, thus helping to prevent spre…
Carlo Foppiano Palacios, Amit C. Achhra, Lydia Barakat, Michael Virata, Richie Hao, et al.
…at increased risk of reactivation of tuberculosis (TB) from latent tuberculosis infection (LTBI). Current guidelines recommend all PWH be initially screened for LTBI with either interferon-gamma release assays (IGRA) or tuberculin skin testing (TST). Also, repeat screening is rec…
Nunzi A, Della Valle L, Lindfors Rossi EL, Ranucci G, Mallegni F, et al.
Background Identification of latent tuberculosis infection (LTBI) is a critical step of tuberculosis surveillance, especially in low-incidence countries. However, it is limited to situations with a higher probability of developing active disease, e.g., patients with hematological…
Anita Uka, Frédéric Méchaï, Daniela Maria Cirillo, Lorenzo Guglielmetti, Yousra Kherabi, et al.
…imen selection, use of microbiological and molecular tests, treatment regimens for active and latent TB, monitoring practices, and adherence to international (WHO 2022, ERS/ECDC 2017 and IJTLD 2023) guidelines. Descriptive analyses were performed to summarize practices and identi…
Chiang CY, Chen CH, Feng JY, Chiang YJ, Huang WC, et al.
…l proportion of TB among solid organ transplant recipients. Treatment of TB among recipients is complicated by the drug-drug interactions between anti-TB drugs and immunosuppressants. TB is associated with an increased risk of graft rejection, graft failure and mortality. Detecti…
Chris J Griffiths, DPhil, MB BS
…ance level. Secondary outcomes are rates of prophylaxis for latent TB infection (LTBI), BCG immunisation, smear negative (early) TB and costs. Analyses will be by intention to treat. To date, studies of screening for tuberculosis have used relatively weak designs. A randomised t…
Eka Kokhreidze, Zaza Avaliani, Nino Gabashvili, Maia Zamutashvili
The uptake of latent tuberculosis infection treatment (LTBI) is an important measure to prevent active tuberculosis (TB), but has not been well studied in low and middle-income countries (LMICs). The lifetime risk of developing active TB for people with LTBI is 10-15%. Within the…
Kawatsu L, Kaneko N, Imahashi M, Kamada K, Uchimura K
…actor for progression to active TB disease for persons with latent TB infection (LTBI). Screening for active TB and LTBI, and TB preventive therapy (TPT) is recommended, however, clinical practices regarding LTBI screening for HIV positive population have not been uniform, result…
Dr Rajendra Tatu Nanavare
… cancer, especially in individuals with a history of cancer treatment and tobacco use. Through a detailed analysis of clinical cases, we explore the complexities associated with TB reactivation post-cancer therapy and the hurdles in timely diagnosing lung cancer in tobacco users.…
Ammara Masood, Yawen Xiang, Safiya Rose-Hartwell, Sujith Subesinghe
…t Background/Aims The 2018 British Society for Rheumatology guidelines mandate pre-treatment screening for infections (including tuberculosis [TB], viral hepatitis and HIV) in patients prior to treatment initiation with advanced therapies. It is increasingly common for patients t…
Chi‐Lu Chiang, Yuh‐Min Chen, Taiwan Society of Pulmonary and Critical Care Medicine
…c and professional awareness of early evaluation and timely treatment for the disease in individuals with chronic airway symptoms. A recently validated two-stage, risk-stratified strategy combining the COPD Diagnostic Questionnaire with FEV1/FEV6 measurement was demonstrated to b…
Aldon Li, Tawny Belleau, Graciela Faiad
…series of patients who were exposed to TB as defined by CDC Guidelines, identified through contact tracing reports during exposure period April-July 2019. Local infection control protocol was to assess exposed patients with an IGRA initially, then place a PPD if IGRA was inconclu…
Black DA, McBrien SW, Gersh J, Ghassemieh B, Narita M, et al.
…on in the United States will require improved detection and treatment of latent TB infection among non-U.S.-born residents who remain at disproportionate risk of TB disease. To inform targeted testing efforts, we evaluated risk of TB disease among non-U.S.-born residents of Washi…